News

MD Anderson and SNIPR BIOME collaborate to advance next-generation CRISPR read full story

LSP Invests in $83 Million Series A Financing of Evommune read full story

LSP Portfolio Company Cardior Announces €64 M Series B Financing read full story

LSP portfolio company Nouscom announces first patient dosed in a Phase 1b Trial with NOUS-PEV read full story

LSP leads $20 million financing of Visus Therapeutics read full story

LSP Invests in $110 Million Series B Financing of T-knife Therapeutics read full story

LSP Portfolio Company Artios Announces $ 153 Million (£ 110 Million) Series C Financing read full story

LSP's Portfolio Company XyloCor Therapeutics Commences Phase 2 Component read full story

LSP co-leads €60 million Series A financing in Muna Therapeutics read full story

LSP invests in $70 million Series A financing of Xilis read full story

go to archive

MONTHLY REPORTS